helpline 01494 601 400
12/02/2016

3D printed epilepsy drug easier to swallow

Correction: American pharmaceutical company Aprecia has asked us to point out that 3D printing of the drug Spritam (levetiracetam) creates a porous tablet that rapidly dissolves with water. This makes it an important alternative option for people who struggle to swallow their epilepsy medication.

 

3D printing does not alter the absorption of levetiracetam - the active ingredient in the drug - as we wrongly stated in our article headlined 'Epilepsy drug first to be made using 3D printer in US' (27 January 2016).

Aprecia has clarified that 3D printing only affects the tablet formulation, not the efficiency of absorption or the potency of the drug.

We apologise for any confusion.